Previously, researches have demonstrated that increased PD-1 expression on peripheral blood CD8+ T cells was associated with impaired immune function in patients with NSCLC, and with an increasing intensity of immune infiltrates and the presence of lymphoid aggregates [32, 33]. Here, CD8A is linked to non-small cell lung carcinoma.